[Federal Register Volume 85, Number 117 (Wednesday, June 17, 2020)]
[Notices]
[Page 36617]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-13008]
[[Page 36617]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-667]
Importer of Controlled Substances Application: Woodfield
Distribution, LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before July 17, 2020.
Such persons may also file a written request for a hearing on the
application on or before July 17, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on June 3, 2020, Woodfield Distribution, LLC, 951 Clint
Moore Road, Suite A, Boca Raton, Florida 33487-2804, applied to be
registered as an importer of the following basic class(es) of
controlled substance:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Nabilone............................... 7379 II
------------------------------------------------------------------------
The company plans to import this controlled substance for phase I
of a clinical study. Approval of permit applications will occur only
when the registrant's activity is consistent with what is authorized
under 21 U.S.C. 952(a) (2). Authorization will not extend to the import
of Food and Drug Administration (FDA)-approved or non-approved finished
dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-13008 Filed 6-16-20; 8:45 am]
BILLING CODE 4410-09-P